Dried Blood Spot Collection Cards Market Size & Growth Forecast 2027–2036, By Segments (End Use, Card Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Dried Blood Spot Collection Cards Market size stood at USD 430.5 million in 2026 and is predicted to grow at a 5.61% CAGR from 2027 to 2036, reaching USD 743.06 million by 2036. The industry revenue for 2027 is estimated at USD 450.82 million.
Get more details on this report
Request Free Sample ReportDried Blood Spot Collection Cards Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 37.13% market share in 2026, driven by established laboratory workflows, widespread newborn screening programs, and standardized specimen collection practices across clinical and research settings.
- Asia Pacific is expected to grow at a 5.47% CAGR due to expanding adoption of accessible diagnostic sampling, decentralized testing, and cost-effective collection methods across developing healthcare systems.
Segment Momentum
- Whatman 903 held the largest 2026 market share at 43% due to its established use in routine testing programs, consistent sample collection performance, and compatibility with standard laboratory workflows.
- Diagnostics centers are expanding fastest because their high-throughput testing, standardized workflows, and efficient sample processing align well with dried blood spot collection methods, supporting greater operational scalability.
Market Expansion Drivers
- Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods.
- Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies.
- Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions.
Leading Market Participants
- Key players in the dried blood spot collection cards market include F. Hoffmann-La Roche Ltd (Switzerland), QIAGEN N.V. (Germany), PerkinElmer Inc. (United States), Shimadzu Corporation (Japan), Ahlstrom-Munksjö Oyj (Finland), Pall Corporation (United States), Cytiva (United States), Eastern Business Forms, Inc. (United States), Archimed Life Science GmbH (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 430.5 million
- 2027 Estimated Market Size: USD 450.82 million.
- Projected Market Size: USD 743.06 million by 2036
- Growth Forecast: 5.61% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals & Clinics (End Use) | Whatman 903 (Card Type) | New Born Screening (NBS) (Application)
- Emerging Opportunity Segment: Diagnostics Centers (End Use) | FTA (Card Type) | Forensics (Application)
Market Growth Drivers and Industry Trends
Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods
Expansion of newborn screening initiatives is supporting the dried blood spot collection cards market because these programs require practical methods for obtaining and preserving small blood samples from infants. Dried blood spot collection enables blood to be obtained through minimally invasive sampling and transported for laboratory analysis without the logistical requirements associated with conventional liquid blood specimens. The approach is particularly useful for screening programs that need standardized sample collection across hospitals, clinics, and community healthcare settings. As public health systems broaden screening coverage for inherited, metabolic, and other conditions, the convenience of dried sample handling is increasing its relevance within newborn diagnostic workflows.
Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies
Infectious disease testing initiatives are contributing to the dried blood spot collection cards market as healthcare programs increasingly require accessible methods for collecting and transporting blood samples from diverse populations. Dried blood spot techniques require only a small sample volume and can simplify specimen handling in locations where conventional blood collection and refrigerated transportation may be difficult. This makes the approach useful for screening and surveillance activities conducted in community settings, remote locations, and resource-constrained environments. The ability to stabilize collected specimens for subsequent laboratory testing can also support broader testing workflows where immediate processing of liquid blood samples is not practical.
Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions
Growing use of dried blood sampling in forensic investigations and remote diagnostic applications is expanding the dried blood spot collection cards market by increasing demand for convenient sample preservation and transportation methods. In forensic settings, compact blood collection formats can facilitate specimen handling and storage when biological evidence must be transported for laboratory examination. Remote diagnostic programs can similarly benefit from collection methods that allow samples to be obtained outside conventional laboratory environments and transferred for later analysis. Their portability, low sample-volume requirements, and simplified storage characteristics make dried blood spot cards suitable for decentralized testing workflows and field-based sample collection.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Expanding newborn screening programs increasing adoption of dried blood spot diagnostic collection methods | 2.00% | High | North America, Europe | High | Near Term |
| Rising infectious disease testing initiatives supporting wider use of low-volume blood sampling technologies | 1.80% | High | Asia Pacific, Africa | High | Mid Term |
| Growing forensic and remote diagnostic applications strengthening demand for portable sample preservation solutions | 1.40% | Moderate | Latin America, Asia Pacific | Emerging | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America accounted for the largest share of 37.13% in 2026 in the dried blood spot collection cards market, supported by established healthcare and laboratory infrastructure, broad adoption of minimally invasive sample collection methods, and strong demand for convenient biological specimen handling. The region's mature diagnostic ecosystem facilitates the use of dried blood spot sampling across clinical testing, screening, and research applications. Growing emphasis on efficient sample collection, storage, and transportation further reinforces market adoption.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing region, supported by expanding diagnostic capabilities, rising healthcare access, and increasing demand for efficient sample collection methods. The growing penetration of laboratory and screening services is encouraging adoption of dried blood spot technologies, particularly where simplified collection and specimen handling can improve testing accessibility. Investments in healthcare infrastructure and the broader shift toward decentralized and convenient diagnostic approaches are also contributing to the region's growth trajectory.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Laboratory Quality FocusGermany places strong emphasis on high-quality dried blood spot collection cards that support reliable laboratory diagnostics and validated testing protocols. The market benefits from demand for standardized sampling solutions aligned with clinical research and public health laboratory requirements.
France 🇫🇷
Public Health DiagnosticsFrance continues to utilize dried blood spot collection cards across national screening initiatives and clinical laboratory networks. The market prioritizes dependable sample preservation and standardized collection practices that enhance diagnostic consistency for preventive healthcare programs.
Italy 🇮🇹
Specialized Laboratory AdoptionItaly is expanding the application of dried blood spot collection cards within specialized diagnostic laboratories and regional healthcare systems. Healthcare providers are focusing on practical collection solutions that simplify logistics while maintaining analytical performance across diverse testing requirements.
Japan 🇯🇵
Precision Diagnostic SupportJapan is strengthening the use of dried blood spot collection cards in precision diagnostics and long-term disease monitoring programs. Healthcare institutions are seeking collection products that improve sample integrity while supporting efficient laboratory processing across specialized testing applications.
South Korea 🇰🇷
Digital Healthcare IntegrationSouth Korea is incorporating dried blood spot collection cards into expanding digital healthcare and molecular diagnostic services. The country is encouraging convenient sample collection methods that complement remote healthcare delivery and advanced laboratory testing capabilities.
United States 🇺🇸
Clinical Screening ExpansionThe U.S. continues to emphasize dried blood spot collection cards for newborn screening, decentralized clinical research, and infectious disease monitoring. Healthcare providers are prioritizing standardized sample collection workflows that integrate efficiently with laboratory automation and expanding diagnostic programs.
Segment Leadership and Growth Trends
Dried Blood Spot Collection Cards Market Share (%), by End Use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd Use Segment Analysis: Hospitals & Clinics (Largest Segment) vs Diagnostics Centers (Fastest-Growing Segment)
The dried blood spot collection cards market was anchored by hospitals & clinics, which held a 70.4% share in 2026. These healthcare facilities rely on convenient sample collection methods to support diagnostic testing while simplifying the handling and transportation of biological specimens. Dried blood spot cards offer practical advantages for sample collection, storage, and transport, making them useful where conventional specimen handling can be more resource-intensive. Their compatibility with decentralized and laboratory-based diagnostic workflows supports continued demand across hospitals and clinics.
Diagnostics centers are experiencing stronger adoption as the need for accessible and efficient sample collection supports broader use of dried blood spot techniques. These cards can facilitate specimen handling and transportation while reducing logistical complexity associated with conventional sample collection methods. Growing emphasis on decentralized diagnostics, streamlined laboratory workflows, and convenient specimen management is supporting increasing utilization within diagnostic centers.
Card Type Segment Analysis: Whatman 903 (Largest Segment) vs FTA (Fastest-Growing Segment)
Whatman 903 accounted for a 43% share of the dried blood spot collection cards market in 2026, maintaining its leading position through established use in biological specimen collection and analytical workflows. Its suitability for collecting and preserving blood samples supports applications where reliable specimen handling is essential. Familiarity with established card formats and their integration into existing laboratory procedures further contributes to sustained demand for whatman 903 cards.
FTA cards are gaining traction as laboratories and research-oriented users seek collection platforms that simplify sample preservation, handling, and downstream analysis. Their ability to support convenient biological sample management makes them valuable in workflows where transportation and storage efficiency are important. Increasing use of dried blood spot methodologies across diagnostic and research applications is creating favorable conditions for broader adoption of FTA cards.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End Use | Hospitals & Clinics, Diagnostics Centers, Others | Hospitals & Clinics | Diagnostics Centers |
| Card Type | Whatman 903, Ahlstrom 226, FTA, Others | Whatman 903 | FTA |
| Application | New Born Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, CRO/Research, Others | New Born Screening (NBS) | Forensics |
Competitive Landscape and Market Positioning
Top players in the dried blood spot collection cards market:
1. F. Hoffmann-La Roche Ltd (Switzerland)
2. QIAGEN N.V. (Germany)
3. PerkinElmer Inc. (United States)
4. Shimadzu Corporation (Japan)
5. Ahlstrom-Munksjö Oyj (Finland)
6. Pall Corporation (United States)
7. Cytiva (United States)
8. Eastern Business Forms Inc. (United States)
9. Archimed Life Science GmbH (Germany)
The dried blood spot collection cards market is being shaped by the increasing need for convenient sample collection, remote diagnostics, and efficient disease screening programs. Manufacturers are focusing on improved sample preservation technologies, contamination control, and regulatory-compliant materials to enhance testing reliability. Advancements in decentralized healthcare and laboratory automation are also supporting innovation within the dried blood spot collection cards market.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| F. Hoffmann-La Roche Ltd (Switzerland) | |||||||
| QIAGEN N.V. (Germany) | |||||||
| PerkinElmer Inc. (United States) | |||||||
| Shimadzu Corporation (Japan) | |||||||
| Ahlstrom-Munksjö Oyj (Finland) | |||||||
| Pall Corporation (United States) | |||||||
| Cytiva (United States) | |||||||
| Eastern Business Forms Inc. (United States) | |||||||
| Archimed Life Science GmbH (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Capitainer | Jan-24 | Capitainer launched miQro Lab Solutions, a U.S.-based laboratory in Rhode Island, to accelerate integration of its self-sampling and micro-sampling technologies into the U.S. healthcare system. The initiative is positioned to support broader adoption of decentralized blood collection solutions and improve clinical accessibility and operational efficiency. |
| Neoteryx (Trajan Scientific) | Sep-22 | Neoteryx, part of Trajan Scientific, launched a program supporting micro-sampling pilot studies by providing Mitra devices to healthcare and research organizations. The initiative enables evaluation of remote blood sampling feasibility across clinical and research environments, supporting adoption of decentralized sample collection methods. |
| Capitainer | Sep-22 | Capitainer reported positive performance results for its qDBS volumetric dried blood spot card, demonstrating accurate diagnostic outcomes for phenylketonuria. The technology addresses limitations of conventional DBS cards by improving volume consistency and reducing variability caused by hematocrit effects, strengthening reliability in remote blood sampling applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Dried Blood Spot Collection Cards Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Testing Workflow | Manual Testing Workflows, Automated Testing Workflows, High-Throughput Testing Workflows |
| Analyte Type | Nucleic Acids, Proteins & Biomarkers, Small Molecules & Metabolites, Therapeutic Drugs |
| Procurement Channel | Direct Manufacturer Procurement, Distributors & Medical Supply Wholesalers, Institutional & Government Procurement |
Dried Blood Spot Collection Cards Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Newborn Screening Program Expansion Assessment |
|
| Decentralized Diagnostics Adoption Assessment |
|
| Home-Based Sample Collection Opportunity Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the current size of the dried blood spot collection cards market?
What is the forecasted size of the dried blood spot collection cards industry?
Which healthcare delivery trends are accelerating demand for dried blood spot collection cards?
How are remote and decentralized testing applications influencing purchasing decisions in the market?
Which card type leads the dried blood spot collection cards market?
Why are diagnostics centers the fastest-growing end-use segment in the dried blood spot collection cards market?
What factors support North America's leadership in the dried blood spot collection cards market?
Why is Asia Pacific the fastest-growing region for dried blood spot collection cards?
Who are the leading players in the dried blood spot collection cards landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization